Saturday, October 10, 2026

@cfrischer1 42h ago

Charles Frischer on X

@amuuhasuo $NN Curious how you get to 4 billion valuation. We own almost 14 MHz. I believe Grain is closer to 2 per pop since it is currently 5x5. 14 MHz is 4.5 billion pops. Times 2 is 9 billion or 45 per share.

@calvinblissett Oct 10

Calvin Blissett on X

$OC https://t.co/pA9b0mDR9D https://t.co/Mx02ZpE88d

@cfrischer1 Oct 10

Charles Frischer on X

@amuuhasuo That is beyond not likely. The way they indicate no would be to do nothing. Let’s face it, SpaceX buying Grain is great comp for $NN. Some days are good for shareholders, some days aren’t. This was a fantastic news day for NN. Throw stones on a bad day, today isn’t that day.

@calvinblissett Oct 10 2 clicks

Calvin Blissett on X

$CHRD: 6.5x FCF, Good CEO, buying back lots of stock, low-cost pure play EP. 8% FCF yield at $60 WTI. No meaningful leverage CHRD trades at ~$142, market cap ~$7.74B, enterprise value ~$8.63B. Dividend yield ~3.7% ($5.20 annual base). Buyback/total shareholder yield is higher: policy returns ≥75% of adjusted free cash flow (mostly buybacks after the base dividend) at current low leverage (<0.5x). On 2026 guidance of ~$1.3B Adj. FCF, this implies a potential total cash return yield in the low-to-mid teens. Valuation is low: ~9.5x TTM P/E, ~7.6x forward P/E, EV/EBITDA ~3.2-3.6x, P/FCF ~6.5x. Analyst consensus PT ~$166-174 (~20%+ upside); highs to $193. Marcellus non-op sale (to POSCO, expected Q4 2026 close) provides ~$550M gross proceeds, sharpening pure-play Williston focus, boosting cash/flexibility for returns or balance-sheet strength, and removing a non-core asset. Reasons for future growth: Flat-to-low absolute oil volumes (maintenance program ~161 MBopd oil) but rising per-share metrics via efficiency and buybacks. Longer laterals (majority of program, including 4-mile) cut costs/breakevens and improve recovery; base production enhancements and lower declines support volumes with less capital. Pure-play focus post-sale plus disciplined consolidator role in the Bakken. Efficiency gains already drove material FCF improvements. LTM Owner’s Earnings (Buffett-style): Roughly Net Income + DD&A + other non-cash charges − maintenance CapEx (and normalized for WC/one-time items). For this E&P, nearly all CapEx is maintenance to offset natural declines, so Owner’s Earnings approximates free cash flow. TTM (to ~Jun 30, 2026): Operating cash flow ~$2.59B, CapEx ~$1.40B → FCF ~$1.19B. DD&A ~$1.54B; Net Income ~$841M. Company-reported adjusted FCF (preferred operational proxy) was strong in 1H26 (~$738M combined Q1+Q2) and has been running at an elevated rate. This is a rigorous, cash-based measure after the capital required to sustain the business. Expected next-12-months Owner’s Earnings: ~$1.3B adjusted free cash flow (company 2026 guidance, including derivatives, at $75 WTI / $3 HH for 2H). Why higher than LTM: stronger realized oil prices vs. prior periods, operational efficiencies (longer laterals, cost controls, base enhancements), volumes at/above high-end of prior guidance, and capital discipline (CapEx held ~$1.4B midpoint). The $550M Marcellus proceeds is one-time cash (not recurring earnings) that further supports returns and balance-sheet optionality. At ≥75% payout, this supports substantial shareholder distributions while maintaining a strong BS. Business simply: Pure-play Williston Basin (Bakken) E&P—largest operator there. Drills oil-focused horizontal wells, produces/sells crude, NGLs, and gas. High-quality inventory; shift to longer laterals improves economics. Management: Danny Brown (CEO; prior Oasis/Anadarko). Track record of efficiency, synergies, disciplined capital allocation, and per-share value creation. Capital allocation: Base dividend + aggressive buybacks under the 75%+ Adj. FCF framework (leverage-dependent). Share count reduced meaningfully; cumulative returns large relative to market cap. Maintenance production focus. Risks: Oil price sensitivity/volatility (primary driver), basin decline/inventory longevity, execution on laterals or M&A, regulatory factors in ND/MT, energy transition headwinds. Margin of safety & upside: Low leverage, high cash generation even at moderate oil prices ($60-70 WTI still supports solid FCF/returns), conservative CapEx, and efficiency gains provide protection. Upside from multiple expansion toward peers/history, continued buyback accretion to per-share metrics, operational outperformance, oil strength, and pure-play clarity. Consensus implies ~20%+ near-term upside; higher in stronger commodity scenarios. Attractive FCF yield + value profile in E&P. Figures based on company results/guidance, market data, and analyst notes as of early October 2026. Oil prices and execution remain key variables.

@calvinblissett Oct 10

Calvin Blissett on X

$OC: Trading at an $11B market cap and 5x EBITDA, Owens Corning (NYSE: OC) presents a compelling asymmetric investment thesis as a forecasted >90% probability 2026/2027 "Super El Niño" prepares to drive massive, non-discretionary, insurance-funded roofing repair demand across the Southeast United States. Historical parallels from the 2015–2016 and 2023–2024 El Niño cycles demonstrate clear operating leverage, where severe storm activity doubled roofing EBIT and generated 2x to 3x stock returns within 12 to 24 months. Modeling a 35% (base) to ~50% (bull) EBITDA expansion at a standard 9x EV/EBITDA multiple points to a 2x base-case to nearly 3x bull-case upside over the next 12 months, supported by a ~2.5% dividend yield and tactical plant expansions in Ohio and Alabama. Primary risks include asphalt input price spikes linked to high crude oil prices and ongoing integration or tariff friction from the $3.9B Masonite acquisition. However, the thesis features a deep margin of safety anchored by a elevated trough EBITDA margin floor of 24–34% (up from 13–16% in past cycles), cost-saving vertical integration via in-house asphalt oxidation, and strict insurance policy timelines that compel homeowners to replace damaged roofs regardless of broader macroeconomic weakness.

@ACapitalLP Oct 9

A Capital on X

I wonder if Russia/Ukraine will come to some sort of agreement soon? 🤷‍♂️ $KYIV https://t.co/kkm1TDJbPf

@KEDM_COM Oct 9 2 clicks

KEDM.com on X

Qiagen $QGEN has had a new CEO (Jonathan Pratt) since Sept. 1. Let's see if he can bring some action. The company also recently confirmed it continues to evaluate strategic alternatives, with Goldman Sachs involved. There have been reports of takeover interest for a long time, with past reports linking Qiagen to Thermo Fisher, bioMérieux, and Bio-Rad. Qiagen is an interesting target given its leadership in nucleic acid prep, strong consumables-driven revenue, and growth areas like TB testing and digital PCR. The portfolio would fit well with major industry consolidators.